Hageman Factor Deficiency
National Organization for Rare Disorders, Inc.
Synonyms
- Factor XII Deficiency
- HAF Deficiency
- Hageman Trait
Disorder Subdivisions
General Discussion
Hageman Factor Deficiency is a rare inherited blood disorder that causes prolonged clotting (coagulation) of blood in a test tube without the presence of prolonged clinical bleeding tendencies. It is caused by a deficiency of the Hageman factor (Factor XII), a plasma protein (glycoprotein). Although it is thought that Factor XII is needed for blood clotting, when it is deficient, other blood clotting factors tend to compensate for its absence. This disorder is thought to be benign and usually presents no symptoms (asymptomatic); it is usually only accidentally discovered through pre-operative blood tests that are required by hospitals. Of substantial recent interest is the role of antibodies to Factor XII in recurrent pregnancy losses. .
Symptoms
Usually no symptoms are present or obvious. However, when blood from a patient is subjected to a partial thromboplastin time test (PTT), a test measuring clotting time, it takes an abnormally long time for the blood to clot. Serum prothrombin time, another test of blood clotting, is also abnormally long. The blood level of Hageman Factor (Factor XII) tends to vary greatly.
It is important to note that on rare occasions Hageman Factor Deficiency may cause blood clots (thrombi) at an early age. Blood clots can have serious consequences. If a clot interrupts blood supply to the heart (myocardial infarction), the heart muscle itself may be damaged. Another reported result of Hageman Factor Deficiency is inflammation of the vein associated with a blood clot (thrombophlebitis). .
Causes
Hageman Factor Deficiency is transmitted as an autosomal recessive disorder. The defective gene has been traced to Gene Map Locus 5q33-qter. Chromosomes are found in the nucleus of all body cells. They carry the genetic characteristics of each individual. Pairs of human chromosomes are numbered from 1 through 22, with an unequal 23rd pair of X and Y chromosomes for males and two X chromosomes for females. Each chromosome has a short arm designated as p and a long arm identified by the letter q. Chromosomes are further subdivided into bands that are numbered. For example, chromosome 11p15.4 refers to band 15.4 on the short arm of chromosome 11.
Human traits including the classic genetic diseases, are the product of the interaction of two genes for that condition, one received from the father and one from the mother. In recessive disorders, the condition does not appear unless a person inherits the same defective gene from each parent. If one receives one normal gene and one gene for the disease, the person will be a carrier for the disease, but usually will show no symptoms. The risk of transmitting the disease to the children of a couple, both of whom are carriers for a recessive disorder, is twenty-five percent. Fifty percent of their children will be carriers, but healthy as described above. Twenty-five percent of their children will receive both normal genes, one from each parent and will be genetically normal (for that particular trait).) The exact mechanism of inheritance is still being investigated. The risk is the same for each pregnancy. .
Affected Populations
Hageman Factor Deficiency affects persons of Asian descent more often than those of European descent. Males and females are affected in equal numbers. In about 10% of cases, the parents of patients with this disorder are closely related. .
Related Disorders
Symptoms of the following disorders can be similar to those of Hageman Factor Deficiency. Comparisons may be useful for a differential diagnosis:
Factor IX Deficiency is a severe genetic bleeding disorder that resembles classic Hemophilia A, although it occurs only one-fifth as often as Hemophilia. Factor IX is a component of the blood clotting substance, thromboplastin; it is deficient at birth in patients with this disorder. Factor IX Deficiency varies in severity and occurs most often in males. In rare instances, female carriers have been known to exhibit this deficiency in a mild form. Symptoms include prolonged bleeding episodes, and in very severe cases, joint pain and bone deformities. (For more information on this disorder, choose "Factor IX" as your search term in the Rare Disease Database.)
Factor XIII Deficiency is an extremely rare genetic bleeding disorder. It is characterized by slow, oozing internal bleeding occurs several days after mild or severe injury. Poor wound healing and excessive bleeding from wounds are less common symptoms. About 100 cases of Factor XIII Deficiency have been described in the medical literature. Males and females are affected equally. With treatment, patients with this disorder can expect to live a normal life span. Without treatment, however, intracranial bleeding may eventually be life threatening. (For more information on this disorder, choose "Factor XIII" as your search term in the Rare Disease Database.)
Standard Therapies
Diagnosis Hageman Factor Deficiency can be diagnosed by testing the blood of a person suspected to have the disorder with blood from a person known to have it. If the suspected blood does not correct the deficiency in the deficient blood, we know it is deficient as well. Treatment for this disorder is usually not necessary since the bleeding is only mild. .
References
McKusick VA., ed. Online Mendelian Inheritance in Man (OMIM). Baltimore. MD: The Johns Hopkins University; Entry No: 234000; Last Update: 6/3/2002.
TEXTBOOKS Hoffman R, et al., eds. Hematology Basic Principles and Practice, 2nd ed. New York, NY: Churchill-Livingstone, Inc; 1995:1581-83, 1699.
Bennett JC, Plum F., eds. Cecil Textbook of Medicine. 20th ed. Philadelphia, PA: W.B. Saunders Co; 1996:988.
Beers MH, Berkow R., eds. The Merck Manual, 17th ed. Whitehouse Station, NJ: Merck Research Laboratories; 1999:904-05.
REVIEW ARTICLES Sugi T, Makino T. Autoantibodies to contact proteins in patients with recurrent pregnancy losses. J Reprod Immunol. 2002;53:269-77.
Baker WF Jr, Bick RL. Treatment of hereditary and acquired thrombophilic disorders. Semin Thromb Hemost. 1999;25:387-406.
JOURNAL ARTICLES Jones DW, Gallimore MJ, Winter M. Recurerent abortion-antibodies to factor XII or a decrease in factor XII levels? Fertil Steril. 2001;76:1288-89.
Ogasawara MS, Iinuma Y, Aoki K, et al. Low-dose aspirin is effective for treatment of recurrent miscarriage in patients with decreased coagulation factor XII. Fertil Steril. 2001;76:203-04.
Matsuura T, Kobayashi T, Asahina T, et al. Is factor XII deficiency related to recurrent miscarriage. Semin Thromb Hemost. 2001;27:115-20.
Helft G, Le Feuvre C, Metzger JP, et al. Factor XII deficiency associated with coronary stent thrombosis. Am J Hematol. 2000;64:322-23.
Zeerleder S, Schloesser M, Redondo M, et al. Reevaluation of the incidence of thromboembolic complications in congenital Factor XII deficiency—a study on 73 subjects from 14 Swiss families. Thromb Haemost. 1999;82:1240-46.
FROM THE INTERNET Elstrom R. MEDLINEplus. Medical Encyclopedia. Factor XII (Hageman factor) deficiency. Last Update: 10/14/01:2pp. www.nlm.nih.gov/medlineplus/ency
Canadian Hemophilia Society. Other factor Deficiencies. Factor XII Deficiency. 2002:1p. www.hemophilia.ca/english/other/other/factor12.html
Resources
National Hemophilia Foundation
116 West 32nd Street 11th Floor New York, NY 10001 USA Tel: 2123283737 Fax: 2123283795 Tel: 8004242634 Email: gwidlundDhemophilia.org Internet: http://www.hemophilia.org
NIH/National Heart, Lung and Blood Institute Information Center
P.O. Box 30105 Bethesda, MD 20824-0105 Tel: (301)592-8573 Fax: (301)251-1223 Email: nhlbiinfo@rover.nhlbi.nih.gov
For a Complete Report
This is an abstract of a report from the National Organization for Rare Disorders, Inc.® (NORD). A copy of the complete report can be obtained for a small fee by visiting the NORD website. The complete report contains additional information including symptoms, causes, affected population, related disorders, standard and investigational treatments (if available), and references from medical literature. For a full-text version of this topic, see http://www.rarediseases.org/search/rdblist.html.
The information provided in this report is not intended for diagnostic purposes. It is provided for
informational purposes only. NORD recommends that affected individuals seek the advice or counsel of
their own personal physicians.
It is possible that the title of this topic is not the name you selected. Please check the Synonyms
listing to find the alternate name(s) and Disorder Subdivision(s) covered by this report
This disease entry is based upon medical information available through the date at the end of the
topic. Since NORD's resources are limited, it is not possible to keep every entry in the Rare Disease
Database completely current and accurate. Please check with the agencies listed in the Resources section
for the most current information about this disorder.
For additional information and assistance about rare disorders, please contact the National Organization
for Rare Disorders at P.O. Box 1968, Danbury, CT 06813-1968; phone (203) 744-0100; web site
www.rarediseases.org or email orphan@rarediseases.org
Last Updated: 9/25/2002
Copyright 1988, 1989, 2002
National Organization for Rare Disorders, Inc.
|
|
|
This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
|
|